Reliability of Conclusions from Early Analyses of Real-World Data for Newly Approved Drugs in Advanced Gastric Cancer in the United States.
Lisa M HessMichael GrabnerLiya WangAstra M LiepaXiaohong Ivy LiZhanglin Lin CuiLee BowmanWilliam R SchelmanPublished in: Pragmatic and observational research (2020)
Since treatment effectiveness may change across lines of treatment, bias may arise if there are changes in the use of the drug (such as line migration) during the time period of analysis using real-world data.